Physician profile
Robert Lee Percell
NPI 1316025505
$918,317.11
in general payments reported to CMS, 2019-2025
16 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112K · 2020: $60K · 2021: $21K · 2022: $179K · 2023: $340K · 2024: $170K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $403K · Travel and Lodging: $108K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $403,188.51 |
| Travel and Lodging | $108,498.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,185.00 |
| Food and Beverage | $10,431.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $812,648.53 | 2019-2025 | Amplatzer Amulet, Aveir, Amplatzer Piccolo |
| Janssen Pharmaceuticals, INC | $72,686.65 | 2019-2024 | Xarelto |
| Siemens Medical Solutions USA, INC. | $21,747.59 | 2024-2025 | Acuson Origin Diagnostic Ultrasound System, Acuson Sc2000 Diagnostic Ultrasound System, Acuson Sequoia Diagnostic Ultrasound System |
| E.R. Squibb & Sons, L.L.C. | $7,255.10 | 2019-2020 | |
| Biosense Webster, INC. | $2,350.48 | 2019-2024 | Carto 3, Nuvision Ice Catheter, Pentaray Nav |
| Boston Scientific Corporation | $978.99 | 2019-2025 | Farapulse |
| Philips North America LLC | $167.36 | 2019-2025 | Lm Undivided, (Am5) Lead Management |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.12 | 2019-2025 | Lifevest |
| Preventice Services, LLC | $99.91 | 2021 | |
| Impulse Dynamics (USA) INC. | $99.16 | 2022-2024 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $69.01 | 2019-2021 | |
| Itamar Medical INC | $36.79 | 2022 | |
| Cardiofocus, INC. | $29.78 | 2019 | |
| Pfizer INC. | $23.43 | 2019 | |
| Allergan, INC. | $14.21 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Percell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.